Literature DB >> 21782446

Association between apolipoprotein E genotypes and Parkinson's disease.

T Pulkes1, C Papsing, S Mahasirimongkol, M Busabaratana, K Kulkantrakorn, S Tiamkao.   

Abstract

Previous studies on the association between apolipoprotein E (APOE) alleles and Parkinson's disease (PD) have shown contradictory results. A recent study showed that APOE is involved in a molecular pathway of α-synuclein-induced neurodegeneration. We therefore conducted the first Thai study on APOE genotypes in patients with PD. We analysed the frequencies of APOE genotypes in our case-control study of 155 patients with sporadic PD and 158 control participants. We identified a higher frequency of the APOE-ε2 allele among patients with PD than among controls (odds ratio=2.309, 95% confidence interval=1.111-4.799). Genetic association is a powerful tool for detecting disease susceptibility alleles, but there are many pitfalls to consider before claiming any association. The discrepancy among the results of the genetic association studies of APOE genotypes as a risk of susceptibility to PD emphasises that this association merits clarification by the study of a single large homogeneous population.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782446     DOI: 10.1016/j.jocn.2011.01.028

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  12 in total

1.  APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease.

Authors:  Neeraj Kumar Singh; Basu Dev Banerjee; Kiran Bala; Aldrin Anthony Dung Dung; Neelam Chhillar
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

Review 2.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 3.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

4.  Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.

Authors:  Michele L Gregório; Marcela A S Pinhel; Caroline L Sado; Gabriela S Longo; Fábio N Oliveira; Gisele S Amorim; Marcelo A Nakazone; Greiciane M Florim; Camila M Mazeti; Denise P Martins; Waldir A Tognola; Antonio C Brandão; Sidney Pinheiro Júnior; Moacir F de Godoy; Dorotéia R S Souza
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

Review 5.  Emerging preclinical pharmacological targets for Parkinson's disease.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Oncotarget       Date:  2016-05-17

6.  Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study.

Authors:  Ashish Kumar Gupta; Komal Rani; Surabhi Swarnkar; Gaurav Khunger Kumar; Mohd Imran Khan; Ruchika Pokhriyal; Domada Ratna Kumar; Vinay Goyal; Manjari Tripathi; Rishab Gupta; Rakesh Kumar Chadda; Perumal Vanamail; Gururao Hariprasad
Journal:  J Cent Nerv Syst Dis       Date:  2018-10-09

7.  The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.

Authors:  Jianming Li; Jia Luo; Li Liu; Hui Fu; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

Review 9.  Role of apolipoprotein E in neurodegenerative diseases.

Authors:  Vo Van Giau; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-16       Impact factor: 2.570

10.  Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.

Authors:  Cristina Nombela; James B Rowe; Sophie E Winder-Rhodes; Adam Hampshire; Adrian M Owen; David P Breen; Gordon W Duncan; Tien K Khoo; Alison J Yarnall; Michael J Firbank; Patrick F Chinnery; Trevor W Robbins; John T O'Brien; David J Brooks; David J Burn; Roger A Barker
Journal:  Brain       Date:  2014-07-30       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.